HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1166768Generated: November 1, 2026
Potassium Iodide → 3-Chloro-4-hydroxybenzoic Acid {4-[2-(1,2,3,4-Tetrahydroisoquinolin-2-yl)ethoxy]-2-methoxybenzylidene}hydrazide
https://huagongshe.com/reaction/1166768
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Iodide | HCID 4875 | — |
| Reactant | 1,2,3,4-Tetrahydroisoquinoline | HCID 7046 | — |
| Reactant | Ethyl orthoformate | HCID 31214 | — |
| Reactant | 3-Chloro-4-hydroxybenzohydrazide | HCID 10954268 | — |
| Reactant | 4-(2-Bromoethoxy)-2-methoxybenzaldehyde | HCID 22999111 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 3-Chloro-4-hydroxybenzoic Acid {4-[2-(1,2,3,4-Tetrahydroisoquinolin-2-yl)ethoxy]-2-methoxybenzylidene}hydrazide | HCID 85414813 | — |
Reaction Steps
The resin bound 3-chloro-4-hydroxybenzoic acid hydrazide (resin—[building block 1]) (3 g, ˜3 mmoles) was swelled in DMF (35 mL) for 30 minutes. Then 4-(2-bromoethoxy)-2-methoxybenzaldehyde (2.33 g, 9 mmoles) and triethyl orthoformate (18 mL) were added and the mixture was shaken at room temperature for 16 hours. The resin was repeatedly swelled in DMF (35 ml, 4 times), CH2Cl2 (35 mL, 6 times) and N-methyl-2-pyrrolidinone (NMP) (35 mL, 2 times) and filtered. The resin was swelled in NMP (40 mL) and 1,2,3,4-tetrahydroisoquinoline (3.75 mL, 30 mmoles) and potassium iodide (1.0 g, 6 mmoles) were added. The resin was shaken at room temperature for 16 hours and filtered. The resin was repeatedly swelled in DMF (40 ml, 5 times), CH2Cl2 (40 mL, 10 times) and filtered. The compound was cleaved off the resin by shaking for 1 hour at room temperature with a 50% solution of trifluoroacetic acid in CH2Cl2 (40 mL). The mixture was filtered and the resin was extracted with CH2Cl2 (40 mL, 2 times). The combined CH2Cl2 extracts were concentrated in vacuo. The residue was dissolved in CH2Cl2 (40 mL) and concentrated in vacuo. The residue was dissolved in methanol (40 mL) and concentrated in vacuo. The residue was partitioned between ethyl acetate (50 mL) and saturated sodium hydrogencarbonate (50 mL). The aqueous phase was extracted with ethyl acetate (50 mL), and the combined organic extracts were dried over MgSO4 and concentrated in vacuo. The residue was purified by coloumn chromatography over silica gel (200 mL) eluting with a mixture of CH2Cl2 and methanol (9:1). This afforded 280 mg of the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06613942B1 |
|---|
| Source dataset | uspto-grants-2003_09 |
|---|
| ORD ID | ord-b9d0f7e3b1c643d8a39d871be2e8cb32 |
|---|
| Source note | uspto-grants-2003_09 |
|---|